Leukemia and Other Malignancies Among GH Users

Leukemia and Other Malignancies Among GH Users Shaw Watanabe1, Shoichi Mizuno1, Li-Hwa Oshima1, Yukiko Tsunematsu2, Junichiro Fujimoto2 and Atsushi Komiyama3 Leukemia Study Group of the Foundation for Growth Science, Japan l Epidemiology Division, National Cancer Center; 2 Hemato-Oncology Division and Research Institute, National Children's Hospital, 3 Department of Pediatrics, Shinshu University, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104, Japan SYNOPSIS The number of reported cases of leukemia ieveloping in growth hormone (GH) users /orldwide has reached 31. Twelve Japanese ases are briefly reviewed; five each of AML and ÜLL, and one each of CML and malignant hisiocytosis. The underlying diseases of these >atients consisted of 8 idiopathic disease, 3 umors and one Fanconi's anemia. Leukemia >ccurred during GH treatment in 9 cases and titer cessation of GH in 3. The longest interval rom the cessation of GH therapy was 10 years. jH administration from a younger age tended ο be linked to myeloid type: Risk factors and possible mechanisms of leukemogenesis by growth hormone are discussed, and proposals or the future have been made by the Foundation or Growth Science in Japan. INTRODUCTION Administration of growth hormone is inavoidable for the treatment of pituitary Iwarfism. Although a risk of leukemia has been predicted based on experiments in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Pediatric Endocrinology and Metabolism de Gruyter

Loading next page...
 
/lp/de-gruyter/leukemia-and-other-malignancies-among-gh-users-dDeSYx2iX0
Publisher
de Gruyter
Copyright
Copyright © 1993 by the
ISSN
0334-018X
eISSN
2191-0251
DOI
10.1515/JPEM.1993.6.1.99
Publisher site
See Article on Publisher Site

Abstract

Shaw Watanabe1, Shoichi Mizuno1, Li-Hwa Oshima1, Yukiko Tsunematsu2, Junichiro Fujimoto2 and Atsushi Komiyama3 Leukemia Study Group of the Foundation for Growth Science, Japan l Epidemiology Division, National Cancer Center; 2 Hemato-Oncology Division and Research Institute, National Children's Hospital, 3 Department of Pediatrics, Shinshu University, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104, Japan SYNOPSIS The number of reported cases of leukemia ieveloping in growth hormone (GH) users /orldwide has reached 31. Twelve Japanese ases are briefly reviewed; five each of AML and ÜLL, and one each of CML and malignant hisiocytosis. The underlying diseases of these >atients consisted of 8 idiopathic disease, 3 umors and one Fanconi's anemia. Leukemia >ccurred during GH treatment in 9 cases and titer cessation of GH in 3. The longest interval rom the cessation of GH therapy was 10 years. jH administration from a younger age tended ο be linked to myeloid type: Risk factors and possible mechanisms of leukemogenesis by growth hormone are discussed, and proposals or the future have been made by the Foundation or Growth Science in Japan. INTRODUCTION Administration of growth hormone is inavoidable for the treatment of pituitary Iwarfism. Although a risk of leukemia has been predicted based on experiments in

Journal

Journal of Pediatric Endocrinology and Metabolismde Gruyter

Published: Jan 1, 1993

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off